# OnCo record exemestane (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/exemestane/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "exemestane" ;
  schema:name "Exemestane"@en ;
  schema:description "Exemestane is a steroidal aromatase inhibitor, the partner of everolimus and the agent tested with ovarian suppression in young women."@en ;
  schema:url <https://onco.cc/drugs/exemestane/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Exemestane> ;
  owl:sameAs <http://www.wikidata.org/entity/Q418819> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Exemestane> ;
  onco:status "approved" ;
  onco:modality "Small-molecule steroidal aromatase inactivator" ;
  schema:alternateName "Aromasin" ;
  onco:approval "US 1999: Advanced breast cancer after tamoxifen", "US 2005: Adjuvant after 2-3 years of tamoxifen" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/soft-text/>, <https://onco.cc/trials/evera/>, <https://onco.cc/trials/nct05768139/>, <https://onco.cc/trials/nct06979596/>, <https://onco.cc/trials/nct05774951/>, <https://onco.cc/trials/nct04906395/>, <https://onco.cc/trials/nct06016738/>, <https://onco.cc/trials/nct06957379/>, <https://onco.cc/trials/nct06492616/>, <https://onco.cc/trials/nct06428396/>, <https://onco.cc/trials/nct05514054/>, <https://onco.cc/trials/nct05827081/>, <https://onco.cc/trials/nct05573126/> .